Because the GLP-1 medications have been studied in long-term, randomized clinical trials and have also focused on other disease outcomes besides weight, like arthritis and obstructive sleep apnea
Patients with a history of hormone-sensitive cancers should discuss GHK-Cu with their oncologist before beginning a protocol
King to VTA: FDA has no enforcement discretion policy for TDN or NTN products VTA received a letter from Director King on February 2, 2023 outlining CTPs formal position on enforcement discretion regarding tobacco-derived nicotine (TDN) and non-tobacco/synthetic nicotine (NTN) products
Blurred vision, new floaters, or sudden vision loss should always be checked by a doctor
Employers should also consider the potential impact on related conditions, healthcare utilization, and long-term health outcomes
Reconstitution of Retatrutide In my case, because I had 15mg of Retatrutide Peptide, I reconstituted it with 1.5ml of reconstitution solution